Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Change in Acquisitions & Divestments (2017 - 2025)

Historic Change in Acquisitions & Divestments for Anaptysbio (ANAB) over the last 9 years, with Q3 2025 value amounting to $123.0 million.

  • Anaptysbio's Change in Acquisitions & Divestments rose 1177.27% to $123.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $442.8 million, marking a year-over-year decrease of 1147.06%. This contributed to the annual value of $476.1 million for FY2024, which is 592.95% up from last year.
  • As of Q3 2025, Anaptysbio's Change in Acquisitions & Divestments stood at $123.0 million, which was up 1177.27% from $90.6 million recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Change in Acquisitions & Divestments registered a high of $149.2 million during Q4 2022, and its lowest value of $9.6 million during Q1 2022.
  • Its 5-year average for Change in Acquisitions & Divestments is $97.0 million, with a median of $101.4 million in 2022.
  • As far as peak fluctuations go, Anaptysbio's Change in Acquisitions & Divestments crashed by 8479.87% in 2022, and later surged by 129424.12% in 2023.
  • Anaptysbio's Change in Acquisitions & Divestments (Quarter) stood at $25.5 million in 2021, then skyrocketed by 485.29% to $149.2 million in 2022, then decreased by 22.44% to $115.8 million in 2023, then dropped by 20.75% to $91.7 million in 2024, then soared by 34.01% to $123.0 million in 2025.
  • Its Change in Acquisitions & Divestments was $123.0 million in Q3 2025, compared to $90.6 million in Q2 2025 and $137.4 million in Q1 2025.